Listed

Benitec Biopharma Inc.

BNTCNasdaqCIK 1808898HealthcareFiscal year ends Jun 30

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q3 FY2026
Operating income−$14.4m, Q4 FY2026
Net income−$12.8m, Q4 FY2026
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q4 FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30
Revenue$m0.0Revenue, Q1 FY2024, three months to 2023-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-14, accession 0001193125-24-258672.Report this figure0.0Revenue, Q2 FY2024, three months to 2023-12-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-02-14, accession 0001193125-25-026631.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-14, accession 0001193125-25-119383.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2024-09-26, accession 0001193125-24-226968. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2025, three months to 2024-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-14, accession 0001193125-25-283274.Report this figure0.0Revenue, Q2 FY2025, three months to 2024-12-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-12, accession 0001193125-26-047737.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figurenot reported0.0Revenue, Q1 FY2026, three months to 2025-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-14, accession 0001193125-25-283274.Report this figure0.0Revenue, Q2 FY2026, three months to 2025-12-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-12, accession 0001193125-26-047737.Report this figure0.0Revenue, Q3 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figurenot reported
Research and development$m4.4Research and development, Q1 FY2024, three months to 2023-09-30$4.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001193125-24-258672.Report this figure5.1Research and development, Q2 FY2024, three months to 2023-12-31$5.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-02-14, accession 0001193125-25-026631.Report this figure2.6Research and development, Q3 FY2024, three months to 2024-03-31$2.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001193125-25-119383.Report this figure3.5Research and development, Q4 FY2024, three months to 2024-06-30$3.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K/A filed 2026-03-20, accession 0001193125-26-117604. Derived: 12-month figure less the 9-month figure.Report this figure3.6Research and development, Q1 FY2025, three months to 2024-09-30$3.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K/A filed 2026-03-20, accession 0001193125-26-117604.Report this figure5.4Research and development, Q2 FY2025, three months to 2024-12-31$5.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-12, accession 0001193125-26-047737.Report this figure6.5Research and development, Q3 FY2025, three months to 2025-03-31$6.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure2.9Research and development, Q4 FY2025, three months to 2025-06-30$2.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K/A filed 2026-03-20, accession 0001193125-26-117604.Report this figure3.4Research and development, Q1 FY2026, three months to 2025-09-30$3.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001193125-25-283274.Report this figure5.8Research and development, Q2 FY2026, three months to 2025-12-31$5.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-12, accession 0001193125-26-047737.Report this figure6.3Research and development, Q3 FY2026, three months to 2026-03-31$6.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure7.9Research and development, Q4 FY2026, three months to 2026-06-30$7.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-09-14, accession 0001193125-26-390570. Derived: 12-month figure less the 9-month figure.Report this figure
Operating income$m(5.9)Operating income, Q1 FY2024, three months to 2023-09-30−$5.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001193125-24-258672.Report this figure(6.9)Operating income, Q2 FY2024, three months to 2023-12-31−$6.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-14, accession 0001193125-25-026631.Report this figure(4.1)Operating income, Q3 FY2024, three months to 2024-03-31−$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001193125-25-119383.Report this figure(5.5)Operating income, Q4 FY2024, three months to 2024-06-30−$5.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K/A filed 2026-03-20, accession 0001193125-26-117604. Derived: 12-month figure less the 9-month figure.Report this figure(5.8)Operating income, Q1 FY2025, three months to 2024-09-30−$5.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K/A filed 2026-03-20, accession 0001193125-26-117604.Report this figure(10.8)Operating income, Q2 FY2025, three months to 2024-12-31−$10.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-12, accession 0001193125-26-047737.Report this figure(15.3)Operating income, Q3 FY2025, three months to 2025-03-31−$15.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure(9.8)Operating income, Q4 FY2025, three months to 2025-06-30−$9.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K/A filed 2026-03-20, accession 0001193125-26-117604.Report this figure(9.8)Operating income, Q1 FY2026, three months to 2025-09-30−$9.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-283274.Report this figure(13.4)Operating income, Q2 FY2026, three months to 2025-12-31−$13.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-12, accession 0001193125-26-047737.Report this figure(13.6)Operating income, Q3 FY2026, three months to 2026-03-31−$13.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure(14.4)Operating income, Q4 FY2026, three months to 2026-06-30−$14.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-09-14, accession 0001193125-26-390570. Derived: 12-month figure less the 9-month figure.Report this figure
Net income$m(6.0)Net income, Q1 FY2024, three months to 2023-09-30−$6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-14, accession 0001193125-25-119383.Report this figure(6.8)Net income, Q2 FY2024, three months to 2023-12-31−$6.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-14, accession 0001193125-25-119383.Report this figure(4.3)Net income, Q3 FY2024, three months to 2024-03-31−$4.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-14, accession 0001193125-25-119383.Report this figure(4.7)Net income, Q4 FY2024, three months to 2024-06-30−$4.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2026-03-20, accession 0001193125-26-117604. Derived: 12-month figure less the 9-month figure.Report this figure(5.1)Net income, Q1 FY2025, three months to 2024-09-30−$5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure(9.6)Net income, Q2 FY2025, three months to 2024-12-31−$9.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure(14.5)Net income, Q3 FY2025, three months to 2025-03-31−$14.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure(8.8)Net income, Q4 FY2025, three months to 2025-06-30−$8.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2026-03-20, accession 0001193125-26-117604.Report this figure(9.0)Net income, Q1 FY2026, three months to 2025-09-30−$9.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure(11.8)Net income, Q2 FY2026, three months to 2025-12-31−$11.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure(11.9)Net income, Q3 FY2026, three months to 2026-03-31−$11.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure(12.8)Net income, Q4 FY2026, three months to 2026-06-30−$12.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-09-14, accession 0001193125-26-390570. Derived: 12-month figure less the 9-month figure.Report this figure
Diluted EPS$ per share(3.05)Diluted EPS, Q1 FY2024, three months to 2023-09-30−$3.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001193125-24-258672.Report this figure(2.64)Diluted EPS, Q2 FY2024, three months to 2023-12-31−$2.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-14, accession 0001193125-25-026631.Report this figure(0.23)Diluted EPS, Q3 FY2024, three months to 2024-03-31−$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001193125-25-119383.Report this figurenot reported(0.18)Diluted EPS, Q1 FY2025, three months to 2024-09-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K/A filed 2026-03-20, accession 0001193125-26-117604.Report this figure(0.26)Diluted EPS, Q2 FY2025, three months to 2024-12-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-12, accession 0001193125-26-047737.Report this figure(0.38)Diluted EPS, Q3 FY2025, three months to 2025-03-31−$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure(0.21)Diluted EPS, Q4 FY2025, three months to 2025-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K/A filed 2026-03-20, accession 0001193125-26-117604.Report this figure(0.22)Diluted EPS, Q1 FY2026, three months to 2025-09-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001193125-25-283274.Report this figure(0.26)Diluted EPS, Q2 FY2026, three months to 2025-12-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-12, accession 0001193125-26-047737.Report this figure(0.24)Diluted EPS, Q3 FY2026, three months to 2026-03-31−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figurenot reported
Basic EPS$ per share(3.05)Basic EPS, Q1 FY2024, three months to 2023-09-30−$3.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001193125-24-258672.Report this figure(2.64)Basic EPS, Q2 FY2024, three months to 2023-12-31−$2.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-02-14, accession 0001193125-25-026631.Report this figure(0.23)Basic EPS, Q3 FY2024, three months to 2024-03-31−$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001193125-25-119383.Report this figurenot reported(0.18)Basic EPS, Q1 FY2025, three months to 2024-09-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K/A filed 2026-03-20, accession 0001193125-26-117604.Report this figure(0.26)Basic EPS, Q2 FY2025, three months to 2024-12-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-12, accession 0001193125-26-047737.Report this figure(0.38)Basic EPS, Q3 FY2025, three months to 2025-03-31−$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure(0.21)Basic EPS, Q4 FY2025, three months to 2025-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K/A filed 2026-03-20, accession 0001193125-26-117604.Report this figure(0.22)Basic EPS, Q1 FY2026, three months to 2025-09-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001193125-25-283274.Report this figure(0.26)Basic EPS, Q2 FY2026, three months to 2025-12-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-12, accession 0001193125-26-047737.Report this figure(0.24)Basic EPS, Q3 FY2026, three months to 2026-03-31−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figurenot reported

Balance sheet

Cash and equivalents$180.0m, FY2026
Shareholders' equity$177.0m, FY2026
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31FY20262026-06-30
Cash and equivalents$m25.9Cash and equivalents, Q1 FY2024, at 2023-09-30$25.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001193125-23-275377.Report this figure20.4Cash and equivalents, Q2 FY2024, at 2023-12-31$20.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-02-13, accession 0001193125-24-032940.Report this figure14.1Cash and equivalents, Q3 FY2024, at 2024-03-31$14.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-13, accession 0001193125-24-136727.Report this figure50.9Cash and equivalents, FY2024, at 2024-06-30$50.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K/A filed 2026-03-20, accession 0001193125-26-117604.Report this figure67.8Cash and equivalents, Q1 FY2025, at 2024-09-30$67.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001193125-24-258672.Report this figure78.3Cash and equivalents, Q2 FY2025, at 2024-12-31$78.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-02-14, accession 0001193125-25-026631.Report this figure104Cash and equivalents, Q3 FY2025, at 2025-03-31$103.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001193125-25-119383.Report this figure97.7Cash and equivalents, FY2025, at 2025-06-30$97.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-09-14, accession 0001193125-26-390570.Report this figure94.5Cash and equivalents, Q1 FY2026, at 2025-09-30$94.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001193125-25-283274.Report this figure189Cash and equivalents, Q2 FY2026, at 2025-12-31$188.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-02-12, accession 0001193125-26-047737.Report this figure185Cash and equivalents, Q3 FY2026, at 2026-03-31$184.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure180Cash and equivalents, FY2026, at 2026-06-30$180.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-09-14, accession 0001193125-26-390570.Report this figure
Current assets$m26.4Current assets, Q1 FY2024, at 2023-09-30$26.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001193125-23-275377.Report this figure20.8Current assets, Q2 FY2024, at 2023-12-31$20.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-02-13, accession 0001193125-24-032940.Report this figure14.4Current assets, Q3 FY2024, at 2024-03-31$14.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0001193125-24-136727.Report this figure51.7Current assets, FY2024, at 2024-06-30$51.7m. XBRL concept us-gaap:AssetsCurrent. 10-K/A filed 2026-03-20, accession 0001193125-26-117604.Report this figure68.3Current assets, Q1 FY2025, at 2024-09-30$68.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001193125-24-258672.Report this figure78.7Current assets, Q2 FY2025, at 2024-12-31$78.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-02-14, accession 0001193125-25-026631.Report this figure104Current assets, Q3 FY2025, at 2025-03-31$104.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001193125-25-119383.Report this figure98.5Current assets, FY2025, at 2025-06-30$98.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-09-14, accession 0001193125-26-390570.Report this figure95.1Current assets, Q1 FY2026, at 2025-09-30$95.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001193125-25-283274.Report this figure190Current assets, Q2 FY2026, at 2025-12-31$189.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-02-12, accession 0001193125-26-047737.Report this figure186Current assets, Q3 FY2026, at 2026-03-31$186.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure182Current assets, FY2026, at 2026-06-30$181.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-09-14, accession 0001193125-26-390570.Report this figure
Total assets$m27.1Total assets, Q1 FY2024, at 2023-09-30$27.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001193125-23-275377.Report this figure21.4Total assets, Q2 FY2024, at 2023-12-31$21.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-13, accession 0001193125-24-032940.Report this figure15.0Total assets, Q3 FY2024, at 2024-03-31$15.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0001193125-24-136727.Report this figure52.2Total assets, FY2024, at 2024-06-30$52.2m. XBRL concept us-gaap:Assets. 10-K/A filed 2026-03-20, accession 0001193125-26-117604.Report this figure68.8Total assets, Q1 FY2025, at 2024-09-30$68.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001193125-24-258672.Report this figure79.1Total assets, Q2 FY2025, at 2024-12-31$79.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-02-14, accession 0001193125-25-026631.Report this figure105Total assets, Q3 FY2025, at 2025-03-31$105.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001193125-25-119383.Report this figure99.6Total assets, FY2025, at 2025-06-30$99.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-09-14, accession 0001193125-26-390570.Report this figure96.0Total assets, Q1 FY2026, at 2025-09-30$96.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001193125-25-283274.Report this figure191Total assets, Q2 FY2026, at 2025-12-31$190.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-02-12, accession 0001193125-26-047737.Report this figure187Total assets, Q3 FY2026, at 2026-03-31$187.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure183Total assets, FY2026, at 2026-06-30$182.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-09-14, accession 0001193125-26-390570.Report this figure
Current liabilities$m4.5Current liabilities, Q1 FY2024, at 2023-09-30$4.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001193125-23-275377.Report this figure5.7Current liabilities, Q2 FY2024, at 2023-12-31$5.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-02-13, accession 0001193125-24-032940.Report this figure3.4Current liabilities, Q3 FY2024, at 2024-03-31$3.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-13, accession 0001193125-24-136727.Report this figure4.9Current liabilities, FY2024, at 2024-06-30$4.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K/A filed 2026-03-20, accession 0001193125-26-117604.Report this figure4.6Current liabilities, Q1 FY2025, at 2024-09-30$4.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001193125-24-258672.Report this figure3.1Current liabilities, Q2 FY2025, at 2024-12-31$3.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-02-14, accession 0001193125-25-026631.Report this figure7.0Current liabilities, Q3 FY2025, at 2025-03-31$7.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001193125-25-119383.Report this figure1.8Current liabilities, FY2025, at 2025-06-30$1.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-09-14, accession 0001193125-26-390570.Report this figure2.0Current liabilities, Q1 FY2026, at 2025-09-30$2.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0001193125-25-283274.Report this figure2.8Current liabilities, Q2 FY2026, at 2025-12-31$2.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-02-12, accession 0001193125-26-047737.Report this figure3.3Current liabilities, Q3 FY2026, at 2026-03-31$3.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure5.3Current liabilities, FY2026, at 2026-06-30$5.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-09-14, accession 0001193125-26-390570.Report this figure
Total liabilities$m4.7Total liabilities, Q1 FY2024, at 2023-09-30$4.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001193125-23-275377.Report this figure5.9Total liabilities, Q2 FY2024, at 2023-12-31$5.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-02-13, accession 0001193125-24-032940.Report this figure3.5Total liabilities, Q3 FY2024, at 2024-03-31$3.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0001193125-24-136727.Report this figure5.0Total liabilities, FY2024, at 2024-06-30$5.0m. XBRL concept us-gaap:Liabilities. 10-K/A filed 2026-03-20, accession 0001193125-26-117604.Report this figure4.6Total liabilities, Q1 FY2025, at 2024-09-30$4.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001193125-24-258672.Report this figure3.1Total liabilities, Q2 FY2025, at 2024-12-31$3.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-02-14, accession 0001193125-25-026631.Report this figure7.6Total liabilities, Q3 FY2025, at 2025-03-31$7.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001193125-25-119383.Report this figure2.3Total liabilities, FY2025, at 2025-06-30$2.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-09-14, accession 0001193125-26-390570.Report this figure2.4Total liabilities, Q1 FY2026, at 2025-09-30$2.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0001193125-25-283274.Report this figure3.3Total liabilities, Q2 FY2026, at 2025-12-31$3.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-02-12, accession 0001193125-26-047737.Report this figure3.7Total liabilities, Q3 FY2026, at 2026-03-31$3.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure5.6Total liabilities, FY2026, at 2026-06-30$5.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-09-14, accession 0001193125-26-390570.Report this figure
Shareholders' equity$m22.3Shareholders' equity, Q1 FY2024, at 2023-09-30$22.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-14, accession 0001193125-25-119383.Report this figure15.5Shareholders' equity, Q2 FY2024, at 2023-12-31$15.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-14, accession 0001193125-25-119383.Report this figure11.5Shareholders' equity, Q3 FY2024, at 2024-03-31$11.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-14, accession 0001193125-25-119383.Report this figure47.2Shareholders' equity, FY2024, at 2024-06-30$47.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-14, accession 0001193125-26-390570.Report this figure64.2Shareholders' equity, Q1 FY2025, at 2024-09-30$64.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure75.9Shareholders' equity, Q2 FY2025, at 2024-12-31$75.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure97.6Shareholders' equity, Q3 FY2025, at 2025-03-31$97.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure97.3Shareholders' equity, FY2025, at 2025-06-30$97.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-14, accession 0001193125-26-390570.Report this figure93.6Shareholders' equity, Q1 FY2026, at 2025-09-30$93.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure187Shareholders' equity, Q2 FY2026, at 2025-12-31$187.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure183Shareholders' equity, Q3 FY2026, at 2026-03-31$183.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure177Shareholders' equity, FY2026, at 2026-06-30$177.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-14, accession 0001193125-26-390570.Report this figure

Cash flow

Operating cash flow−$4.9m, Q4 FY2026
Capital expenditure$79.0k, Q4 FY2026
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q4 FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30
Operating cash flow$k(4,577)Operating cash flow, Q1 FY2024, three months to 2023-09-30−$4.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001193125-24-258672.Report this figure(5,365)Operating cash flow, Q2 FY2024, three months to 2023-12-31−$5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-02-14, accession 0001193125-25-026631. Derived: 6-month figure less the 3-month figure.Report this figure(6,168)Operating cash flow, Q3 FY2024, three months to 2024-03-31−$6.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001193125-25-119383. Derived: 9-month figure less the 6-month figure.Report this figure(3,293)Operating cash flow, Q4 FY2024, three months to 2024-06-30−$3.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K/A filed 2026-03-20, accession 0001193125-26-117604. Derived: 12-month figure less the 9-month figure.Report this figure(4,586)Operating cash flow, Q1 FY2025, three months to 2024-09-30−$4.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001193125-25-283274.Report this figure(7,703)Operating cash flow, Q2 FY2025, three months to 2024-12-31−$7.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-12, accession 0001193125-26-047737. Derived: 6-month figure less the 3-month figure.Report this figure(3,086)Operating cash flow, Q3 FY2025, three months to 2025-03-31−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-222885. Derived: 9-month figure less the 6-month figure.Report this figure(8,213)Operating cash flow, Q4 FY2025, three months to 2025-06-30−$8.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-14, accession 0001193125-26-390570. Derived: 12-month figure less the 9-month figure.Report this figure(3,351)Operating cash flow, Q1 FY2026, three months to 2025-09-30−$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001193125-25-283274.Report this figure(3,776)Operating cash flow, Q2 FY2026, three months to 2025-12-31−$3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-12, accession 0001193125-26-047737. Derived: 6-month figure less the 3-month figure.Report this figure(4,452)Operating cash flow, Q3 FY2026, three months to 2026-03-31−$4.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-222885. Derived: 9-month figure less the 6-month figure.Report this figure(4,939)Operating cash flow, Q4 FY2026, three months to 2026-06-30−$4.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-14, accession 0001193125-26-390570. Derived: 12-month figure less the 9-month figure.Report this figure
Capital expenditure$knot reportednot reportednot reported0.0Capital expenditure, Q4 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K/A filed 2026-03-20, accession 0001193125-26-117604. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported6.0Capital expenditure, Q3 FY2025, three months to 2025-03-31$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001193125-26-222885. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-09-14, accession 0001193125-26-390570. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported15.0Capital expenditure, Q3 FY2026, three months to 2026-03-31$15.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001193125-26-222885. Derived: 9-month figure less the 6-month figure.Report this figure79.0Capital expenditure, Q4 FY2026, three months to 2026-06-30$79.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-09-14, accession 0001193125-26-390570. Derived: 12-month figure less the 9-month figure.Report this figure

Shares

Diluted shares (weighted)49.39m, Q3 FY2026
Line itemUnitQ2 FY20232022-12-31Q3 FY20232023-03-31Q1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31
Diluted shares (weighted)m shares1.6Diluted shares (weighted), Q2 FY2023, three months to 2022-12-311,621,280 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-02-13, accession 0001193125-24-032940.Report this figure1.6Diluted shares (weighted), Q3 FY2023, three months to 2023-03-311,645,951 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-13, accession 0001193125-24-136727.Report this figure2.2Diluted shares (weighted), Q1 FY2024, three months to 2023-09-302,157,065 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001193125-24-258672.Report this figure2.6Diluted shares (weighted), Q2 FY2024, three months to 2023-12-312,576,347 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-02-14, accession 0001193125-25-026631.Report this figure18.3Diluted shares (weighted), Q3 FY2024, three months to 2024-03-3118,281,896 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0001193125-25-119383.Report this figure27.9Diluted shares (weighted), Q1 FY2025, three months to 2024-09-3027,883,624 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K/A filed 2026-03-20, accession 0001193125-26-117604.Report this figure37.3Diluted shares (weighted), Q2 FY2025, three months to 2024-12-3137,254,839 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-12, accession 0001193125-26-047737.Report this figure38.6Diluted shares (weighted), Q3 FY2025, three months to 2025-03-3138,599,453 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure41.2Diluted shares (weighted), Q4 FY2025, three months to 2025-06-3041,161,259 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K/A filed 2026-03-20, accession 0001193125-26-117604.Report this figure41.5Diluted shares (weighted), Q1 FY2026, three months to 2025-09-3041,521,280 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001193125-25-283274.Report this figure46.0Diluted shares (weighted), Q2 FY2026, three months to 2025-12-3145,970,516 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-12, accession 0001193125-26-047737.Report this figure49.4Diluted shares (weighted), Q3 FY2026, three months to 2026-03-3149,386,203 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-222885.Report this figure

Shares outstanding: 34.88mShares outstanding, period not labelled, at 2026-09-0434,882,726 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-K filed 2026-09-14, accession 0001193125-26-390570.Report this figure at Sep 4, 2026, from the cover of the 10-K filed Sep 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.